PMID: 8608037Jan 1, 1995Paper

Development of clinical radiotherapy since 1896

Acta Oncologica
L R Holsti

Abstract

From the discovery of x-rays in November 1895 and the first publication in December 1985 it did not take long for the first x-ray therapy of cancer in January 1896. The first 25 years in the history of radiotherapy was not a very flattering period for the discipline. During the following 25 years, however, important developments in clinical radiotherapy occurred and in some countries the speciality of radiotherapy was established in the 1930s. In the last 50 years gradual changes have taken place and now modern radiotherapy is an established curative method in the treatment of cancer. The scientific background of radiotherapy is solid, and the understanding of cancer biology and radiobiology has improved drastically. The radiotherapists of today are cancer specialists, oncologists. The technical development has been enormous. The future of radiation oncology looks very promising, with local cancer treatment being shown to be most effective.

References

Oct 1, 1975·International Journal of Radiation Oncology, Biology, Physics·J Einhorn, M Thorén
Jan 18, 1992·Lancet·H R Withers
Jan 18, 1992·Lancet·J S Tobias
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Tubiana
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·J F Fowler, M J Lindstrom
Jun 13, 1992·BMJ : British Medical Journal·A Horwich
Aug 1, 1991·International Journal of Radiation Oncology, Biology, Physics·S A LeibelZ Fuks
Jul 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R D Gelber, A Goldhirsch
Sep 1, 1991·International Journal of Radiation Oncology, Biology, Physics·J F Fowler
Jan 1, 1991·International Journal of Radiation Oncology, Biology, Physics·S Dische
Aug 1, 1990·International Journal of Radiation Oncology, Biology, Physics·E Van der SchuerenE Van Limbergen
Jun 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·I Turesson, H D Thames
Aug 1, 1988·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G H Fletcher
Apr 1, 1988·International Journal of Radiation Oncology, Biology, Physics·J T ParsonsR R Million
Jan 1, 1988·Acta Oncologica·H R WithersB Maciejewski
Mar 1, 1987·International Journal of Radiation Oncology, Biology, Physics·J A del Regato
Nov 1, 1985·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·F EdsmyrB Nilsson
Jan 1, 1973·The British Journal of Radiology·G H Fletcher
Jul 1, 1973·The British Journal of Radiology·C G Orton, F Ellis
Feb 1, 1970·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·F Buschke
Jan 1, 1969·Clinical Radiology·F Ellis
Jul 1, 1983·International Journal of Radiation Oncology, Biology, Physics·G H Fletcher
Nov 1, 1982·International Journal of Radiation Oncology, Biology, Physics·G W Barendsen
May 1, 1981·International Journal of Radiation Oncology, Biology, Physics·M Lederman
Feb 1, 1982·International Journal of Radiation Oncology, Biology, Physics·H D ThamesG H Fletcher
Jun 1, 1982·International Journal of Radiation Oncology, Biology, Physics·R S Bush
Dec 1, 1980·International Journal of Radiation Oncology, Biology, Physics·J T ParsonsR R Million
Dec 1, 1994·International Journal of Radiation Oncology, Biology, Physics·E J Hall
May 20, 1993·International Journal of Radiation Oncology, Biology, Physics·M KajantiK Möykkynen
Oct 1, 1952·The British Journal of Radiology·R PATERSON
May 1, 1956·The Journal of Experimental Medicine·T T PUCK, P I MARCUS
Jan 1, 1958·The International Journal of Applied Radiation and Isotopes·G P LABAT, H BRANSON
Mar 1, 1963·The British Journal of Radiology·J F FOWLERB A TURNER
Jan 1, 1945·Acta Radiologica·S MUSTAKALLIO
Jul 1, 1954·The Journal of the Faculty of Radiologists·S MUSTAKALLIO

❮ Previous
Next ❯

Citations

Nov 22, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jonas JohanssonBengt Glimelius
May 5, 1999·Acta Oncologica·B GlimeliusA Montelius
Jul 8, 2016·Biomolecules·Bryan OronskyArnold Oronsky
Nov 7, 2019·Physics in Medicine and Biology·Stefan BartzschMoeava Tehei
Jul 15, 2020·Materials·Motaharesadat Hosseini, Masoud Mozafari
Oct 28, 2019·International Journal of Molecular Sciences·Marco CalvarusoLuigi Minafra
Jan 16, 2020·Immunity·Jérôme Galon, Daniela Bruni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
L Gianni
Computer Methods and Programs in Biomedicine
B JungB Glimelius
© 2021 Meta ULC. All rights reserved